Concepedia

Taebo Sim

TS

Statistics

Publications

90

Citations

8.5K

H-Index

37

Active since

2006

Affiliations

Korea Institute of Science and Technology(Current)

Dana-Farber Cancer Institute

Harvard University

Korea University

Daegu-Gyeongbuk Medical Innovation Foundation

Taebo Sim is an author at Korea Institute of Science and Technology specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryNatural SciencesMedicinal ChemistryCell BiologyBiochemistryDrug DevelopmentCell SignalingSignal Transduction

Publications per year

2006–2024

90

Publications

90

An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1

Carson C. Thoreen, Seong A. Kang, Jae Won Chang et al. · Journal of Biological Chemistry · 2009 · 1.8K citations · Full text

Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

Nicholas Kwiatkowski, Tinghu Zhang, Peter B. Rahl et al. · Nature · 2014 · 882 citations · Full text

Targeting Bcr–Abl by combining allosteric with ATP-binding-site inhibitors

Jianming Zhang, Francisco Adrián, Wolfgang Jahnke et al. · Nature · 2010 · 590 citations

Molecular Pharmacology, Drug Target, Medicine +5

Allosteric inhibitors of Bcr-abl–dependent cell proliferation

Francisco Adrián, Qiang Ding, Taebo Sim et al. · Nature Chemical Biology · 2006 · 376 citations · Full text

Molecular Pharmacology, Medicine, Allosteric Inhibitors +5

Discovery of Potent and Selective Covalent Inhibitors of JNK

Tinghu Zhang, Francisco Iñesta-Vaquera, Mario Niepel et al. · Chemistry & Biology · 2012 · 351 citations · Full text

Medicinal Chemistry, Medicine, Pharmacology +4

1–5 of 90